Related Experiment Video
Updated: Mar 18, 2026
06:13
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
25.7K
Is There an Association Between Indication for Intrauterine Balloon Tamponade and Balloon Failure?
Moeun Son1, Brett D Einerson2, Patrick Schneider3
1Division of Maternal-Fetal Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.
American Journal of Perinatology
|July 2, 2016
Summary
Intrauterine balloon tamponade (IUBT) effectively manages postpartum hemorrhage (PPH) from both uterine atony and placental-site bleeding, with similar failure rates observed for both indications.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Hemorrhage Management
Background:
- Postpartum hemorrhage (PPH) remains a leading cause of maternal morbidity and mortality worldwide.
- Intrauterine balloon tamponade (IUBT) is a recognized intervention for PPH refractory to first-line treatments.
- The comparative effectiveness of IUBT based on the underlying cause of PPH, such as uterine atony versus placental-site bleeding, requires further elucidation.
Purpose of the Study:
- To investigate whether the specific indication for intrauterine balloon tamponade (IUBT) influences its success rates in managing postpartum hemorrhage (PPH).
- To compare the failure rates and secondary outcomes of IUBT when used for uterine atony versus placental-site bleeding.
Main Methods:
- A cohort study was conducted involving women who underwent IUBT for PPH between 2007 and 2014.
- Indications for IUBT were categorized as uterine atony or placental-site bleeding.
- Primary outcome was IUBT failure (requiring uterine artery embolization or hysterectomy); secondary outcomes included estimated blood loss, transfusion requirements, and ICU admission.
Main Results:
- Of 306 women receiving IUBT, 241 (78.8%) had uterine atony and 65 (21.2%) had placental-site bleeding.
- Overall IUBT failure occurred in 21.9% of women, with no significant difference in failure rates between uterine atony (21.2%) and placental-site bleeding (24.6%) groups (p=0.55).
- Secondary outcomes, including estimated blood loss, red blood cell and fresh frozen plasma/cryoprecipitate transfusions, and ICU admission, were also similar between the two indication groups.
Conclusions:
- Intrauterine balloon tamponade demonstrates comparable efficacy in managing postpartum hemorrhage regardless of whether the cause is uterine atony or placental-site bleeding.
- The findings support the use of IUBT as a versatile tool for PPH management across different etiologies.
- Further research could explore patient-specific factors influencing IUBT success beyond the primary indication.
